Eveline Mutsaers – Page 2

Eveline Mutsaers Lawyers Track Record Venture Capital

Strategic partnership between Enzyre and Takeda

We advised Enzyre on its strategic partnership with Takeda whereby Takeda invested in Enzyre. Enzyre develops ground breaking ambulant diagnostic technology focused on blood coagulation.

Niels Hofkes25 March 2021

Eveline Mutsaers Lawyers Track Record Venture Capital

Novish raises growth capital from QSRP

We advised Novish with its investment round in which it received growth capital from QRSP. Novish develops, produces and commercializes plant-based seafood products for the global retail and foodservice markets.

Niels Hofkes4 December 2020

Eveline Mutsaers Homepage Lawyers Track Record Venture Capital

SET Ventures invests in Trunkrs

Wij advised SET Ventures with its investment in Trunkrs. The new financing round in which € 2,2 million was raised, was led by SET Ventures with participation of existing investor Ponooc. Trunkrs is conquering the Dutch market for same day and next day parcel deliveries at a rapid pace. Not only does the company offer fast and reliable deliveries, it also made it their mission to make parcel delivery sustainable.

Niels Hofkes4 November 2020

Eveline Mutsaers Lawyers Track Record Venture Capital

Investment in econic

econic, active in the field of sustainable homes, has secured a new investment of 10 million euro from London-based investment office Rinkelberg Capital. We advised econic and its founder shareholders.

Niels Hofkes5 October 2020

Eveline Mutsaers Lawyers Track Record Uncategorized Venture Capital

Financing round Cellpoint

We advised Cellpoint on its financing round, in which it raised growth capital from NanoDimension. CellPoint is active in the field of immuno-oncology and is developing a disruptive CAR-T production and supply model that allows cancer patients to be treated faster, more effectively and at lower cost.

Niels Hofkes5 August 2020

Eveline Mutsaers Lawyers Track Record Venture Capital

Novalis invests in Enzyre

We advised Enzyre on an investment by Novalis Biotechnology Incubation. Novalis, through its seed fund, participated as co-financer in the Corona Bridge Loan granted by the Dutch government in support of innovative start-ups and scale-ups. Enzyre develops breakthrough ambulant diagnostic technology focused on blood coagulation.

Niels Hofkes25 July 2020

Eveline Mutsaers Lawyers Track Record Venture Capital

Series A Financing of AMT Medical by Oost NL, NextGen Ventures and Utrecht Holdings (UU/UMCU)

We advised AMT Medical with its Series A financing by regional investor Oost NL and existing shareholders NextGen Ventures and Utrecht Holdings (UU / UMCU). AMT Medical is developing a unique coronary bypass system that enables safe, affordable and easy-to-use minimally invasive bypass surgery.

Niels Hofkes4 May 2020

Eveline Mutsaers Lawyers M&A Niels Hofkes Track Record

Flatfield sold to NCAB Group

We advised Standard Investment and the other shareholders of Flatfield with the sale of the shares in Flatfield to NCAB Group. Flatfield is de largest Dutch supplier of Printed Circuit Boards (PCBs). NCAB Group is one of the world's largest suppliers of PCBs, with headquarter in Sweden and listed at NASDAQ Stockholm. NCAB Group strengthens its position in the Benelux and Germany with the acquisition of Flatfield.

Niels_Admin12 March 2020

Eveline Mutsaers Lawyers M&A Track Record

Sale of Gebr. Van der Steen Bedrijven to Van Dorp Groep

We advised the shareholder of Gebr. Van der Steen Bedrijven in the sale of the family business to Van Dorp Groep. Gebr. Van der Steen is specialised in building, managing and maintaining infrastructure under and above ground.

Niels Hofkes4 January 2020

Eveline Mutsaers Lawyers Track Record Venture Capital

SET Ventures invests in Flexidao

We advised SET Ventures on its investment in Flexidao, a start-up in the field of energy and blockchain. Existing shareholder KIC Innoenergy also participated in this round. With this investment Flexidao wants to accelerate the international growth of its blockchain-based energy delivery service and develop new use cases based on the existing middleware platform.

Niels Hofkes14 November 2019